Dolby Laboratories, Inc. (DLB) stock
DLBNYSEPatent Owners & LessorsFiscal year ends September 27
Financials through Q3 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 30, 2026Score 18/305% above fair value
$63.61−0.98 (-1.52%)
Close on Nov 13, 2026Market cap $5.96BP/E 27.1Yield 2.08%
Dolby Laboratories r&d expenses
Research and development expenses are spending on new products and technology.
Dolby Laboratories's R&D Expenses for the twelve months ending Jun 26, 2026 was $265.94M, up 1.1% year over year. For fiscal 2025 it was $261.79M, down 0.7% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $271.52M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 26, 2025 | $261.79M | -0.7% |
| FY2024 | Sep 27, 2024 | $263.66M | -2.9% |
| FY2023 | Sep 29, 2023 | $271.52M | +4.0% |
| FY2022 | Sep 30, 2022 | $261.17M | +3.0% |
| FY2021 | Sep 24, 2021 | $253.64M | +6.1% |
| FY2020 | Sep 25, 2020 | $239.05M | +0.5% |
| FY2019 | Sep 27, 2019 | $237.87M | +0.5% |
| FY2018 | Sep 28, 2018 | $236.79M | +1.5% |
| FY2017 | Sep 29, 2017 | $233.31M | +6.2% |
| FY2016 | Sep 30, 2016 | $219.61M | +9.1% |
| FY2015 | Sep 25, 2015 | $201.32M | +9.9% |
| FY2014 | Sep 26, 2014 | $183.13M | +8.5% |
| FY2013 | Sep 27, 2013 | $168.75M | +20.4% |
| FY2012 | Sep 28, 2012 | $140.14M | +13.1% |
| FY2011 | Sep 30, 2011 | $123.92M | +18.0% |
| FY2010 | Sep 24, 2010 | $104.98M | +28.7% |
| FY2009 | Sep 25, 2009 | $81.54M | +5.2% |
| FY2008 | Sep 26, 2008 | $77.50M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 26, 2026 | $65.75M | -0.4% |
| Q2 FY2026CQ1 2026 | Mar 27, 2026 | $63.65M | +3.2% |
| Q1 FY2026CQ4 2025 | Dec 26, 2025 | $69.08M | +3.7% |
| Q4 FY2025CQ3 2025 | Sep 26, 2025 | $67.47M | -1.7% |
| Q3 FY2025CQ2 2025 | Jun 27, 2025 | $65.98M | +0.7% |
| Q2 FY2025CQ1 2025 | Mar 28, 2025 | $61.71M | -1.3% |
| Q1 FY2025CQ4 2024 | Dec 27, 2024 | $66.64M | -0.6% |
| Q4 FY2024CQ3 2024 | Sep 27, 2024 | $68.64M | -2.5% |
| Q3 FY2024CQ2 2024 | Jun 28, 2024 | $65.50M | -4.7% |
| Q2 FY2024CQ1 2024 | Mar 29, 2024 | $62.49M | -8.0% |
| Q1 FY2024CQ4 2023 | Dec 29, 2023 | $67.03M | +4.0% |
| Q4 FY2023CQ3 2023 | Sep 29, 2023 | $70.43M | +13.5% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $68.70M | +9.3% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $67.95M | +0.8% |
| Q1 FY2023CQ4 2022 | Dec 30, 2022 | $64.45M | -6.4% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $62.07M | +0.2% |
| Q3 FY2022CQ2 2022 | Jul 1, 2022 | $62.86M | +1.2% |
| Q2 FY2022CQ1 2022 | Apr 1, 2022 | $67.42M | +2.5% |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $68.82M | +7.9% |
| Q4 FY2021CQ3 2021 | Sep 24, 2021 | $61.97M | +0.4% |
| Q3 FY2021CQ2 2021 | Jun 25, 2021 | $62.09M | +4.2% |
| Q2 FY2021CQ1 2021 | Mar 26, 2021 | $65.81M | +9.5% |
| Q1 FY2021CQ4 2020 | Dec 25, 2020 | $63.77M | +10.6% |
| Q4 FY2020CQ3 2020 | Sep 25, 2020 | $61.73M | +2.6% |
| Q3 FY2020CQ2 2020 | Jun 26, 2020 | $59.58M | -1.4% |
| Q2 FY2020CQ1 2020 | Mar 27, 2020 | $60.09M | +2.5% |
| Q1 FY2020CQ4 2019 | Dec 27, 2019 | $57.65M | -1.7% |
| Q4 FY2019CQ3 2019 | Sep 27, 2019 | $60.19M | -0.5% |
| Q3 FY2019CQ2 2019 | Jun 28, 2019 | $60.41M | +0.1% |
| Q2 FY2019CQ1 2019 | Mar 29, 2019 | $58.63M | -1.5% |
| Q1 FY2019CQ4 2018 | Dec 28, 2018 | $58.65M | +3.9% |
| Q4 FY2018CQ3 2018 | Sep 28, 2018 | $60.50M | +4.6% |
| Q3 FY2018CQ2 2018 | Jun 29, 2018 | $60.36M | +1.2% |
| Q2 FY2018CQ1 2018 | Mar 30, 2018 | $59.49M | +2.0% |
| Q1 FY2018CQ4 2017 | Dec 29, 2017 | $56.44M | -1.9% |
| Q4 FY2017CQ3 2017 | Sep 29, 2017 | $57.82M | -2.4% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | $59.63M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $58.34M | – |
| Q1 FY2017CQ4 2016 | Dec 30, 2016 | $57.52M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $59.21M | – |
See a number that looks wrong?